Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop

Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review

(2017) Kyla A. McKay et al.   NEUROTOXICOLOGY

High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies

(2016) A K Hedström et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Gut microbiota composition and relapse risk in pediatric MS: A pilot study

(2016) Helen Tremlett et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Observational data: Understanding the real MS world

(2016) Tomas Kalincik et al.   Multiple Sclerosis Journal

Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis

(2016) Prudence Tettey et al.   NEUROEPIDEMIOLOGY

Epidemiology of Multiple Sclerosis

(2016) Jonathan Howard et al.   NEUROLOGIC CLINICS

Health-related quality of life in multiple sclerosis

(2016) Lindsay I. Berrigan et al.   NEUROLOGY

Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis

(2016) Tingting Zhang et al.   NEUROLOGY

Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention—An Update

(2016) Kassandra Munger et al.   SEMINARS IN NEUROLOGY

Alterations of the human gut microbiome in multiple sclerosis

(2016) Sushrut Jangi et al.   Nature Communications

Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort

(2016) Kassandra L. Munger et al.   JAMA Neurology

Observational data: Understanding the real MS world

(2016) Tomas Kalincik et al.   Multiple Sclerosis Journal

Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls

(2016) Jun Chen et al.   Scientific Reports

The Swedish MS registry - clinical support tool and scientific resource

(2015) J. Hillert et al.   ACTA NEUROLOGICA SCANDINAVICA

Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis

(2015) Masaaki Niino et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Body mass index influence interferon-beta treatment response in multiple sclerosis

(2015) Silje Stokke Kvistad et al.   JOURNAL OF NEUROIMMUNOLOGY

Role of the innate and adaptive immune responses in the course of multiple sclerosis

(2015) Bernhard Hemmer et al.   LANCET NEUROLOGY

Implications of dietary salt intake for multiple sclerosis pathogenesis

(2015) Stephanie Hucke et al.   Multiple Sclerosis Journal

Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect

(2015) A Voldsgaard et al.   Multiple Sclerosis Journal

Population attributable fractions and joint effects of key risk factors for multiple sclerosis

(2015) IAF van der Mei et al.   Multiple Sclerosis Journal

Multiple sclerosis—a quiet revolution

(2015) Richard M. Ransohoff et al.   Nature Reviews Neurology

Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study

(2015) Lauren E. Mokry et al.   PLOS MEDICINE

Effect of Smoking Cessation on Multiple Sclerosis Prognosis

(2015) Ryan Ramanujam et al.   JAMA Neurology

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b

(2015) Kathryn C. Fitzgerald et al.   JAMA Neurology

Implications of dietary salt intake for multiple sclerosis pathogenesis

(2015) Stephanie Hucke et al.   Multiple Sclerosis Journal

Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect

(2015) A Voldsgaard et al.   Multiple Sclerosis Journal

Population attributable fractions and joint effects of key risk factors for multiple sclerosis

(2015) IAF van der Mei et al.   Multiple Sclerosis Journal

The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: Study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis

(2014) Pavan Bhargava et al.   Contemporary Clinical Trials

Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review

(2014) R. Goulden et al.   EUROPEAN JOURNAL OF NEUROLOGY

Major stressful life events in adulthood and risk of multiple sclerosis

(2014) Nete Munk Nielsen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study

(2014) Kristin Wesnes et al.   Multiple Sclerosis Journal

Stressful life-events in childhood and risk of multiple sclerosis: a Danish nationwide cohort study

(2014) Nete Munk Nielsen et al.   Multiple Sclerosis Journal

Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis

(2014) A. K. Hedstrom et al.   NEUROLOGY

Chronic caffeine treatment protects against experimental autoimmune encephalomyelitis in mice: Therapeutic window and receptor subtype mechanism

(2014) Tan Wang et al.   NEUROPHARMACOLOGY

Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors

(2014) Milena A. Gianfrancesco et al.   Obesity Research & Clinical Practice

Alcohol as a Modifiable Lifestyle Factor Affecting Multiple Sclerosis Risk

(2014) Anna Karin Hedström et al.   JAMA Neurology

Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression

(2014) Alberto Ascherio et al.   JAMA Neurology

Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study

(2013) Ali Manouchehrinia et al.   BRAIN

Smoking and multiple sclerosis susceptibility

(2013) Anna Karin Hedström et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

The physical anthropometry, lifestyle habits and blood pressure of people presenting with a first clinical demyelinating event compared to controls: The Ausimmune study

(2013) Anne-Louise Ponsonby et al.   Multiple Sclerosis Journal

Childhood body mass index and multiple sclerosis risk: a long-term cohort study

(2013) Kassandra L Munger et al.   Multiple Sclerosis Journal

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

(2013) Ashley H Beecham et al.   NATURE GENETICS

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS

(2013) G. Ristori et al.   NEUROLOGY

Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome

(2013) A. Langer-Gould et al.   NEUROLOGY

A randomised, double blind, placebo controlled trial with vitamin D3as an add on treatment to interferon β-1b in patients with multiple sclerosis

(2012) Merja Soilu-Hänninen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women

(2012) Anna K Hedström et al.   Multiple Sclerosis Journal

Caffeine and alcohol intakes have no association with risk of multiple sclerosis

(2012) J Massa et al.   Multiple Sclerosis Journal

Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial

(2012) Margitta T Kampman et al.   Multiple Sclerosis Journal

Smoking as a risk factor for multiple sclerosis

(2012) Jonatan Salzer et al.   Multiple Sclerosis Journal

T cells become licensed in the lung to enter the central nervous system

(2012) Francesca Odoardi et al.   NATURE

The initiation and prevention of multiple sclerosis

(2012) Alberto Ascherio et al.   Nature Reviews Neurology

Organic Solvents as Risk Factor for Autoimmune Diseases: A Systematic Review and Meta-Analysis

(2012) Carolina Barragán-Martínez et al.   PLoS One

Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial

(2012) Jan Dörr et al.   Trials

Smoking and Increased Risk of Multiple Sclerosis: Parallel Trends in the Sex Ratio Reinforce the Evidence

(2011) Natalia Palacios et al.   ANNALS OF EPIDEMIOLOGY

Autoimmune disease: A role for new anti-viral therapies?

(2011) David H. Dreyfus   AUTOIMMUNITY REVIEWS

Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients

(2011) Ghasem Mosayebi et al.   IMMUNOLOGICAL INVESTIGATIONS

Cholecalciferol Plus Calcium Suppresses Abnormal PBMC Reactivity in Patients with Multiple Sclerosis

(2011) Samantha Kimball et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial

(2011) Joost Smolders et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

The impact of environmental infections (parasites) on MS activity

(2011) Jorge Correale et al.   Multiple Sclerosis Journal

Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination

(2011) Kerstin Berer et al.   NATURE

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

(2011) Stephen Sawcer et al.   NATURE

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis

(2011) M. S. Stein et al.   NEUROLOGY

Smoking and Multiple Sclerosis: An Updated Meta-Analysis

(2011) Adam E. Handel et al.   PLoS One

Dietary Vitamin D3 Supplements Reduce Demyelination in the Cuprizone Model

(2011) Stig Wergeland et al.   PLoS One

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

(2010) Sreeram V Ramagopalan et al.   LANCET NEUROLOGY

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis

(2010) J. M. Burton et al.   NEUROLOGY

Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis

(2010) Y. K. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score

(2009) Philip L De Jager et al.   LANCET NEUROLOGY

Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis

(2009) A. K. Hedstrom et al.   NEUROLOGY

Body size and risk of MS in two cohorts of US women

(2009) K. L. Munger et al.   NEUROLOGY

Multiple sclerosis: major histocompatibility complexity and antigen presentation

(2009) Sreeram V Ramagopalan et al.   Genome Medicine

Impact of exposure to war stress on exacerbations of multiple sclerosis

(2008) Daniel Golan et al.   ANNALS OF NEUROLOGY

Smoking is a risk factor for early conversion to clinically definite multiple sclerosis

(2008) F Di Pauli et al.   Multiple Sclerosis Journal

Comorbidity delays diagnosis and increases disability at diagnosis in MS

(2008) R. A. Marrie et al.   NEUROLOGY